Comorbid Psychiatric Diagnoses Among Individuals Presenting to an Addiction Treatment Program for Alcohol Dependence

REFERENCES

• Arseneault, L., Cannon, M., Witton, J., & Murray, R. M. (2004). Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry, 184, 110–117.
   PubMed Web of Science ®Google Scholar
• Banerjee, S., Clancy, C., & Crome, I. (2002). Coexisting problems of mental disorder and substance misuse (dual diagnosis): An information manual. London: Royal College of Psychiatrists Research Unit.
   Google Scholar
• Bedi, G., Van Dam, N., & Redman, J. J. (2010). Ecstasy (MDMA) and high prevalence psychiatric symptomatology: Somatic anxiety symptoms are associated with polydrug, not ecstasy, use. Psychopharmacol, 24(2), 233–240.
   Google Scholar
• Bischof, G., Rumpf, H. J., Meyer, C., Hapke, U., & John, U. (2005). Influence of psychiatric comorbidity in alcohol-dependent subjects in a representative population survey on treatment utilization and natural recovery. Addiction, 100(3), 405–413.
   PubMed Web of Science ®Google Scholar
• Borges, G., Walters, E. E., & Kessler, R. C. (2000). Associations of substance use, abuse, and dependence with subsequent suicidal behavior. American Journal of Epidemiology, 151(8), 781–789.
   PubMed Web of Science ®Google Scholar
• Di Sclafani, V., Finn, P., & Fein, G. (2007). Psychiatric comorbidity in long-term abstinent alcoholics. Alcoholism, Clinical and Experimental Research, 31(5), 795–803.
   PubMedGoogle Scholar
• Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52(4), 469–476.
   PubMed Web of Science ®Google Scholar
• Falck, R. S., Wang, J., & Carlson, R. G. (2008). Depressive symptomatology in young adults with a history of MDMA use: A longitudinal analysis. Journal of Psychopharmacology, 22(1), 47–54.
   PubMed Web of Science ®Google Scholar
• Farrell, M., Howes, S., Bebbington, P., Brugha, T., Jenkins, R., Lewis, G., (2001). Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. British Journal of Psychiatry, 179, 432–437.
   PubMed Web of Science ®Google Scholar
• Gregg, L., Barrowclough, C., & Haddock, G. (2007). Reasons for increased substance use in psychosis. Clinical Psychology Review, 27(4), 494–510.
   PubMed Web of Science ®Google Scholar
• Guillot, C. (2007). Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? Journal of Psychoactive Drugs, 39(1), 31–39.
   PubMed Web of Science ®Google Scholar
• Hasin, D., Liu, X., Nunes, E., McCloud, S., Samet, S., & Endicott, J. (2002). Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry, 59(4), 375–380.
   PubMed Web of Science ®Google Scholar
• Hesselbrock, M. N., Meyer, R. E., & Keener, J. J. (1985). Psychopathology in hospitalized alcoholics. Archives of General Psychiatry, 42(11), 1050–1055.
   PubMed Web of Science ®Google Scholar
• Huizink, A. C., Ferdinand, R. F., Van Der Ende, J., & Verhulst, F. C. (2006). Symptoms of anxiety and depression in childhood and use of MDMA: Prospective, population based study. British Medical Journal, 332(7545), 825–828.
   PubMed Web of Science ®Google Scholar
• Hunt, G. E., Bergen, J., & Bashir, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: Impact on community survival 4 years after a relapse. Schizophrenia Research, 54(3), 253–264.
   PubMed Web of Science ®Google Scholar
• Johnson, S. (1997). Dual diagnosis of severe mental illness and substance misuse: A case for specialist services? British Journal of Psychiatry, 171, 205–208.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry, 54(4),313–321.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8–19.
   PubMed Web of Science ®Google Scholar
• Lehman, A. F., Myers, C. P., & Corty, E. (1989). Assessment and classification of patients with psychiatric and substance abuse syndromes. Hospital Community Psychiatry, 40(10), 1019–1025.
   PubMedGoogle Scholar
• Manning, V. C., Strathdee, G., Best, D., Keaney, F., Mcgillivray, L., & Witton, J. (2002). Dual diagnosis screening: Preliminary findings on the comparison of 50 clients attending community mental health services and 50 clients attending community substance misuse services. Journal of Substance Use, 7(4), 221–228.
   Google Scholar
• Meisler, N., Blankertz, L., Santos, A. B., & McKay, C. (1997). Impact of assertive community treatment on homeless persons with co-occurring severe psychiatric and substance use disorders. Community Mental Heatlh Journal, 33(2), 113–122.
   PubMed Web of Science ®Google Scholar
• Murphy, G. E., Wetzel, R. D., Robins, E., & McEvoy, L. (1992). Multiple risk factors predict suicide in alcoholism. Archives of General Psychiatry, 49(6), 459–463.
   PubMed Web of Science ®Google Scholar
• Phillips, P., & Johnson, S. (2001). How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Social Psychiatry and Psychiatric Epidemiology, 36(6), 269–276.
   PubMed Web of Science ®Google Scholar
• Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association, 264(19), 2511–2518.
   PubMed Web of Science ®Google Scholar
• Rogers, G., Elston, J., Garside, R., Roome, C., Taylor, R., Younger, P., (2009). The harmful health effects of recreational ecstasy: A systematic review of observational evidence. Health Technology Assessment, 13(6), 1–315.
   Web of Science ®Google Scholar
• Roiser, J. P., Cook, L. J., Cooper, J. D., Rubinsztein, D. C., & Sahakian, B. J. (2005) Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users. American Journal of Psychiatry, 162(3), 609–612.
   PubMedGoogle Scholar
• Rounsaville, B. J., Dolinsky, Z. S., Babor, T. F., & Meyer, R. E. (1987). Psychopathology as a predictor of treatment outcome in alcoholics. Archives of General Psychiatry, 44(6), 505–513.
   PubMed Web of Science ®Google Scholar
• Scott, H., Johnson, S., Menezes, P., Thornicroft, G., Marshall, J., & Bindman, J., (1998). Substance misuse and risk of aggression and offending among the severely mentally ill. British Journal of Psychiatry, 172, 345–350.
   PubMed Web of Science ®Google Scholar
• Sher, L. (2006). Risk and protective factors for suicide in patients with alcoholism. Scientific World Journal, 6, 1405–1411.
   Web of Science ®Google Scholar
• Spremo, M., & Loga, S. (2005). The relationship between suicidal thoughts and psychoactive substances. Bosnian Journal of Basic Medical Science, 5(3), 35–38.
   PubMedGoogle Scholar
• Weaver, T., Renton, A., Stimson, G., & Tyrer, P. (1999). Severe mental illness and substance misuse comorbidity: Research is needed to inform policy and service development. British Medical Journal, 318, 137–138.
   PubMed Web of Science ®Google Scholar